On May 13, 2019, The U.S. Trade Representative (USTR) published a potential expansion of Section 301 tariffs on Chinese products imported into the U.S. The USTR proposal includes assessing tariffs up to 25% covering $300 billion of Chinese-origin imports. If enacted by the U.S Administration, this would be the 4th list, or List 4, of Chinese-origin products assessed additional Section 301 duties.
List 4, as published, includes over 3,700 8-digit U.S. HTS numbers and 18 10-digit U.S. HTS tariff numbers. It represents most remaining U.S. imports of Chinese-origin products not presently assessed Section 301 tariffs. Certain pharmaceutical, medical and mineral imports from China are excluded.
The USTR proposal must first go through procedural steps before it can be enacted by the U.S. Administration. These steps include:
• By June 10, 2019, interested parties must file a request to present comments at a public hearing
• By June 17, 2019, written comments must be received
• On June 17, 2019, a public hearing is scheduled in Washington, D.C., by the Section 301 Committee of the International Trade Commission (ITC) • Within seven days after the close of the public hearing, post-hearing rebuttal comments are due
Section 301 duties may be assessed on List 4 products any time after this process is complete.
In response to the recent U.S. action increasing List 3 Section 301 duties from 10% to 25%, the Chinese government announced increased retaliatory tariffs covering $60 billion of U.S. imports effective June 1st, 2019.
Delmar International will continue to monitor U.S. Section 301 trade developments and provide updated information as it is made available.
Please contact your local Delmar Representative or email our U.S. Customs Advisory Services Group for additional information and assistance.